Whether yours is a communications, life sciences, healthcare, retail, or travel and transportation enterprise, everyone in the commercial industry is facing similar, formidable business challenges.
With Unisys, you’ll have all the solutions and services you need to tackle your most complex business and IT problems, and achieve full digital transformation.
The pressures institutions like yours face are constantly evolving—and getting ahead of them is a real challenge.
Your employees and customers covet new technologies, like digital, mobile, and social. Fintechs and other non-traditional competitors are entering the market in force. And you’re juggling increased expectations, capitalization requirements, regulations, and cyber threats.
With Unisys, you’ll simplify and automate operations, so you can drive sustainable growth and differentiation while delivering an enhanced customer experience.
Transformation in government services is underway now unlike anything in the past decade. The ultimate goal? To promote a safer, more secure world and enhance citizens' lives.
Through a combination of user-centered processes, robust services, and innovative solutions, Unisys helps governments transform digitally with security built in at every step.
Social Technologies Drive Competitive Advantage in Pharmaceuticals
Partner with us to improve performance across the pharmaceutical value chain
With pharmaceutical companies facing enormous cost and productivity pressures, they are increasingly looking for innovative ways to drive meaningful performance improvements. Their complex and distributed nature makes them ideally suited for social business capabilities.
Unisys’ Unified Social Business provides social capabilities targeted to your most critical business needs. From the development of social listening capabilities to dramatically improve the productivity and impact of your medical science liaisons (MSLs), to improving collaboration and knowledge sharing across research teams, social technologies drive game changing capabilities across the value chain.
The reward is clear: Pharmaceutical companies that harness enterprise social business capabilities will be best positioned to succeed.